B

Braidwell Portfolio holdings

AUM $3B
1-Year Est. Return 46.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+46.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3B
AUM Growth
-$129M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
104
New
Increased
Reduced
Closed

Top Buys

1 +$56.7M
2 +$50.2M
3 +$43.9M
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$43.2M
5
ARGX icon
argenx
ARGX
+$42.2M

Top Sells

1 +$82.6M
2 +$59.5M
3 +$50.2M
4
RAPT
RAPT Therapeutics
RAPT
+$31.5M
5
LEGN icon
Legend Biotech
LEGN
+$28.2M

Sector Composition

1 Healthcare 87.27%
2 Financials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
76
Repligen
RGEN
$6.99B
$5.6M 0.19%
47,500
-34,290
HROW icon
77
Harrow
HROW
$1.31B
$5.52M 0.18%
156,419
-138,872
RVTY icon
78
Revvity
RVTY
$11.7B
$4.24M 0.14%
+48,400
CELC icon
79
Celcuity
CELC
$6.48B
$3.33M 0.11%
+29,198
PRAX icon
80
Praxis Precision Medicines
PRAX
$9.76B
$3.21M 0.11%
+9,976
LUNG icon
81
Pulmonx
LUNG
$69.7M
$971K 0.03%
752,541
VYNE icon
82
VYNE Therapeutics
VYNE
$22.7M
$547K 0.02%
+916,077
ADPT icon
83
Adaptive Biotechnologies
ADPT
$2.42B
-311,991
ALGN icon
84
Align Technology
ALGN
$12.5B
-381,004
BIIB icon
85
Biogen
BIIB
$28.9B
-115,700
CSTL icon
86
Castle Biosciences
CSTL
$639M
-177,183
ICLR icon
87
Icon
ICLR
$10.4B
-73,370
KPTI icon
88
Karyopharm Therapeutics
KPTI
$206M
-303,370
LEGN icon
89
Legend Biotech
LEGN
$5.04B
-1,298,142
RAPT
90
DELISTED
RAPT Therapeutics
RAPT
-929,694
RLMD icon
91
Relmada Therapeutics
RLMD
$756M
-1,582,257
TERN
92
DELISTED
Terns Pharmaceuticals
TERN
-575,321
VTYX
93
DELISTED
Ventyx Biosciences
VTYX
-1,920,255
XNCR icon
94
Xencor
XNCR
$881M
-459,166
ORKA
95
Oruka Therapeutics
ORKA
$3.53B
-84,795
BLLN
96
BillionToOne Inc
BLLN
$4.55B
-50,000